When was BriaCell Therapeutics Corp. stock made available for the first time to the public?

The IPO Date for BriaCell Therapeutics Corp. is 2012-03-14. On this 2012-03-14, BriaCell Therapeutics Corp. stock was made publicly available.

Where is the headquarters of BriaCell Therapeutics Corp. stock?

Headquarters of BriaCell Therapeutics Corp. is in CA at Bellevue Centre, West Vancouver, BC V7T 2X1.

What industry does BriaCell Therapeutics Corp. belong to?

The BriaCell Therapeutics Corp. belongs to Biotechnology.

BriaCell Therapeutics Corp.

BCTX•NASDAQ

Healthcare

Biotechnology

$2.06

$-0.05(-2.61%)

BriaCell Therapeutics Corp. (BCTX) Company Profile & Overview

Explore BriaCell Therapeutics Corp.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

BriaCell Therapeutics Corp. (BCTX) Company Profile & Overview

BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing immunotherapies for the treatment of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and development agreement with the National Cancer Institute for developing Bria-OTS, a personalized immunotherapy for advanced breast cancer; and BriaDx, a diagnostic test. BriaCell Therapeutics Corp. is headquartered in West Vancouver, Canada.

SectorHealthcare

IndustryBiotechnology

CEOWilliam V. Williams FCPA,

Contact Information

https://www.briacell.com

604 921 1810

Bellevue Centre, West Vancouver, BC, V7T 2X1

Company Facts

16 Employees

IPO DateMar 14, 2012

CountryCA

Actively Trading

Frequently Asked Questions

;